Venture capitalists poured $2.6 billion into healthcare startups in January, and dozens of healthcare venture capital deals have been announced since then.
Below are 16 healthcare venture capital deal announced in the past month:
1. Imago BioSciences, a San Francisco-based biotechnology company, raised $40 million in Series B financing led by Omega Funds.
2. Arch Oncology, a Brisbane, Calif.-based immuno-oncology company, raised $50 million in Series B funding led by Lightchain.
3. Prevail Therapeutics, a New York City-based gene therapy company, raised $50 million in Series B funding. Existing investors OrbiMed, Pontifax, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners, Boxer Capital and Adage Capital Management were joined by AbbVie Ventures and Surveyor Capital in the funding round.
